Clinical Trials
Mevrometostat/Placebo + Enzalutamide in previously treated prostate cancer patients
Disease Type: Prostate
A Phase 3, Randomized, Double-blind, PlaceboControlled Study Of Mevrometostat (PF-06821497) With Enzalutamide In Metastatic Castration-sensitive Prostate Cancer (MEVPRO-3)
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville